Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-14 Sale | 2023-09-18 5:34 pm | REATA PHARMACEUTICALS INC | RETA | Loewen Andrea SVP, Global Regulatory Affairs | 3,175 | $172.03 | $546,181 | 28,416 (Direct) | View |
| 2023-05-12 Sale | 2023-05-16 4:17 pm | REATA PHARMACEUTICALS INC | RETA | Loewen Andrea SVP, Global Regulatory Affairs | 7,166 | $86.01 | $616,352 | 31,591 (Direct) | View |
| 2023-03-07 Sale | 2023-03-09 4:47 pm | REATA PHARMACEUTICALS INC | RETA | Loewen Andrea SVP, Global Regulatory Affairs | 19,036 | $83.43 | $1,588,137 | 73,757 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 4:44 pm | REATA PHARMACEUTICALS INC | RETA | Loewen Andrea SVP, Global Regulatory Affairs | 1,819 | $88.08 | $160,209 | 42,793 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-26 Disposition | 2023-09-26 4:30 pm | N/A 2030-02-24 | REATA PHARMACEUTICALS INC | RETA | Loewen Andrea SVP, Global Regulatory Affairs | 131,404 | $0 | 0 (Direct) | View |
| 2023-03-07 Exercise | 2023-03-09 4:47 pm | N/A 2032-01-03 | REATA PHARMACEUTICALS INC | RETA | Loewen Andrea SVP, Global Regulatory Affairs | 15,000 | $0 | 73,757 (Direct) | View |
| 2023-03-07 Exercise | 2023-03-09 4:47 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Loewen Andrea SVP, Global Regulatory Affairs | 15,000 | $27.32 | 73,757 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:50 pm | N/A 2033-01-03 | REATA PHARMACEUTICALS INC | RETA | Loewen Andrea SVP, Global Regulatory Affairs | 59,494 | $0 | 92,350 (Direct) | View |
Ownership | 2022-02-07 4:18 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Loewen Andrea SVP, Global Regulatory Affairs | 0 | $0 | 103,106 (Direct) | View |